Biotech · Public company · Boulder, CO, US
Edgewise Therapeutics, Inc.
Ticker EWTX · SEC CIK 0001710072
Track this companyFree. Adds Edgewise Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials185 recruiting or active
Pipeline programs25From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline25
- EDG-15400 25 mgPhase 2 · Heart Failure With Preserved Ejection FractionClinicalTrials.gov · fetched Nov 12, 2026
- EDG-15400 50 mgPhase 2 · Heart Failure With Preserved Ejection FractionClinicalTrials.gov · fetched Nov 12, 2026
- EDG-7500Phase 2 · Hypertrophic CardiomyopathyClinicalTrials.gov · fetched Nov 12, 2026
- SevasemtenPhase 2 · Becker Muscular DystrophyClinicalTrials.gov · fetched Nov 12, 2026
- Sevasemten 10 mgPhase 2 · Becker Muscular DystrophyClinicalTrials.gov · fetched Nov 12, 2026
- Sevasemten 12.5 mgPhase 2 · Becker Muscular DystrophyClinicalTrials.gov · fetched Nov 12, 2026
- Sevasemten 5 mgPhase 2 · Becker Muscular DystrophyClinicalTrials.gov · fetched Nov 12, 2026
- Sevasemten Dose 1Phase 2 · Duchenne Muscular DystrophyClinicalTrials.gov · fetched Nov 12, 2026
- Sevasemten Dose 2Phase 2 · Duchenne Muscular DystrophyClinicalTrials.gov · fetched Nov 12, 2026
- Sevasemten Dose 3Phase 2 · Duchenne Muscular DystrophyClinicalTrials.gov · fetched Nov 12, 2026
- Sevasemten Dose 4Phase 2 · Duchenne Muscular DystrophyClinicalTrials.gov · fetched Nov 12, 2026
- Sevasemten Dose 5Phase 2 · Duchenne Muscular DystrophyClinicalTrials.gov · fetched Nov 12, 2026
- [14C]-EDG-7500Phase 1 · Healthy VolunteerClinicalTrials.gov · fetched Nov 12, 2026
- EDG-15400Phase 1 · Healthy AdultsClinicalTrials.gov · fetched Nov 12, 2026
- EDG-5506Phase 1 · Muscular DystrophiesClinicalTrials.gov · fetched Nov 12, 2026
- EDG-5506Phase 1 · Healthy VolunteerClinicalTrials.gov · fetched Nov 12, 2026
- EDG-5506 TabletPhase 1 · Healthy VolunteerClinicalTrials.gov · fetched Nov 12, 2026
- EDG-7500Phase 1 · Renal ImpairmentsClinicalTrials.gov · fetched Nov 12, 2026
- EDG-7500Phase 1 · Hepatic Impairment (HI)ClinicalTrials.gov · fetched Nov 12, 2026
- EDG-7500Phase 1 · Healthy SubjectsClinicalTrials.gov · fetched Nov 12, 2026
- EDG-7500Phase 1 · Healthy Adult ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
- Radiolabeled EDG-5506 IntravenousPhase 1 · Healthy VolunteerClinicalTrials.gov · fetched Nov 12, 2026
- Radiolabeled EDG-5506 SuspensionPhase 1 · Healthy VolunteerClinicalTrials.gov · fetched Nov 12, 2026
- sevasemtenPhase 1 · Healthy SubjectsClinicalTrials.gov · fetched Nov 12, 2026
- VerapamilPhase 1 · Healthy SubjectsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials18
- A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)PHASE2 · RECRUITING · started Aug 25, 2026ClinicalTrials.gov NCT07795814 · fetched Nov 12, 2026
- A Study to Evaluate EDG-7500 in Caucasian and Japanese AdultsPHASE1 · COMPLETED · started Mar 10, 2026ClinicalTrials.gov NCT07456059 · fetched Nov 12, 2026
- A Study to Evaluate EDG-7500 in Adults With Hepatic ImpairmentPHASE1 · COMPLETED · started Jan 26, 2026ClinicalTrials.gov NCT07324616 · fetched Nov 12, 2026
- A Study of EDG-15400 in Healthy AdultsPHASE1 · COMPLETED · started Aug 20, 2025ClinicalTrials.gov NCT07177066 · fetched Nov 12, 2026
- A Study to Evaluate EDG-7500 in People With Renal ImpairmentPHASE1 · COMPLETED · started Jul 22, 2025ClinicalTrials.gov NCT07034768 · fetched Nov 12, 2026
- A Study to Evaluate Effect of Verapamil and Food of Sevasemten in Healthy VolunteersPHASE1 · COMPLETED · started Jan 8, 2025ClinicalTrials.gov NCT06916897 · fetched Nov 12, 2026
- A Study to Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C]-EDG-7500PHASE1 · COMPLETED · started Dec 3, 2024ClinicalTrials.gov NCT06738836 · fetched Nov 12, 2026
- A Study of EDG-7500 in Adults With Hypertrophic Cardiomyopathy (CIRRUS-HCM)PHASE2 · ACTIVE_NOT_RECRUITING · started Apr 11, 2024ClinicalTrials.gov NCT06347159 · fetched Nov 12, 2026
- Phase 2 Study of EDG-5506 in Children and Adolescents With Duchenne Muscular Dystrophy Previously Treated With Gene TherapyPHASE2 · ACTIVE_NOT_RECRUITING · started Mar 22, 2024ClinicalTrials.gov NCT06100887 · fetched Nov 12, 2026
- Open-Label Extension of EDG-5506 in Participants With Becker Muscular DystrophyPHASE2 · ENROLLING_BY_INVITATION · started Nov 2, 2023ClinicalTrials.gov NCT06066580 · fetched Nov 12, 2026
- A Study of EDG-7500 in Healthy AdultsPHASE1 · COMPLETED · started Aug 14, 2023ClinicalTrials.gov NCT06011317 · fetched Nov 12, 2026
- Absorption, Metabolism, Excretion and Absolute Bioavailability of EDG-5506 in Healthy VolunteersPHASE1 · COMPLETED · started Jan 12, 2023ClinicalTrials.gov NCT05730842 · fetched Nov 12, 2026
- Phase 2 Study of EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON)PHASE2 · COMPLETED · started Nov 10, 2022ClinicalTrials.gov NCT05291091 · fetched Nov 12, 2026
- A Study of EDG-5506 in Children With Duchenne Muscular Dystrophy (LYNX)PHASE2 · ACTIVE_NOT_RECRUITING · started Oct 24, 2022ClinicalTrials.gov NCT05540860 · fetched Nov 12, 2026
- A Study to Assess the Feasibility of Non-invasive Dried Blood SamplingPHASE1 · COMPLETED · started Aug 12, 2022ClinicalTrials.gov NCT05492734 · fetched Nov 12, 2026
- Defining Endpoints in Becker Muscular DystrophyCOMPLETED · started Apr 13, 2022ClinicalTrials.gov NCT05257473 · fetched Nov 12, 2026
- A Study of EDG-5506 in Adult Males With Becker Muscular DystrophyPHASE1 · COMPLETED · started Dec 28, 2021ClinicalTrials.gov NCT05160415 · fetched Nov 12, 2026
- A Study to Assess Safety, Tolerability, and PK of EDG-5506 in Healthy Volunteers and Becker Muscular Dystrophy AdultsPHASE1 · COMPLETED · started Oct 12, 2020ClinicalTrials.gov NCT04585464 · fetched Nov 12, 2026
SEC filings12
- 8-K · FORM 8-KSEC EDGAR · filed Nov 4, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Nov 4, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 6, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Aug 6, 2026 · fetched Nov 12, 2026
- 8-K/A · FORM 8-K/ASEC EDGAR · filed Jul 16, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Jul 13, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Jun 5, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 1, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed May 7, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 7, 2026 · fetched Nov 12, 2026
- 10-K · 10-KSEC EDGAR · filed Feb 26, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Feb 26, 2026 · fetched Nov 12, 2026